Back to Search Start Over

LINC00152/miR-139-5p regulates gastric cancer cell aerobic glycolysis by targeting PRKAA1.

Authors :
Sun K
Hu P
Xu F
Source :
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2018 Jan; Vol. 97, pp. 1296-1302. Date of Electronic Publication: 2017 Dec 14.
Publication Year :
2018

Abstract

Gastric cancer is one of the most common cancers in the world and glycolysis is a major feature of gastric cancer. MicroRNAs (miRNAs) involve in gastric cancer cell proliferation, glycolysis and other cellular processes. MiR-139-5p is reported as a tumor suppressor in cancers, however, the role of miR-139-5p including glycolytic metabolism is unclear in gastric cancer. So, the purpose of the present study is to elucidate the underlying mechanism in gastric cancer metabolism mediated by miR-139-5p. Our results revealed that miR-139-5p inhibited glycolysis by regulating AMP-activated, alpha 1 catalytic subunit (PRKAA1) expression in gastric cancer cells. We also found that miR-139-5p was down-regulated by long intergenic non-coding RNA 152 (LINC00152) in gastric cancer cells. Our results indicate that LINC00152/miR-139-5p facilitates gastric cancer cell glycolysis by regulating PRKAA1 expression.<br /> (Copyright © 2017 Elsevier Masson SAS. All rights reserved.)

Details

Language :
English
ISSN :
1950-6007
Volume :
97
Database :
MEDLINE
Journal :
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Publication Type :
Academic Journal
Accession number :
29156518
Full Text :
https://doi.org/10.1016/j.biopha.2017.11.015